"L’Institut Curie, acteur de référence de la lutte contre le cancer, associe un Centre de Recherche de renommée internationale et un Ensemble Hospitalier de pointe qui prend en charge tous les cancers, y compris les plus rares. Fondé en 1909 par Marie Curie, l’Institut Curie rassemble sur trois sites (Paris, Saint-Cloud, Orsay) plus de 3 300 chercheurs, médecins et soignants autour de trois missions : la recherche, les soins et la conservation et la transmission des savoirs. Fondation privée reconnue d’utilité publique habilitée à recevoir des dons et des legs, l’Institut Curie peut, grâce au soutien de ses donateurs, favoriser les découvertes et ainsi améliorer les traitements et la qualité de vie des malades."

During the past decade, Institut Curie - Section Medicale conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Curie - Section Medicale" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 4 trials sponsored, "UNICANCER" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Gustave Roussy, Cancer Campus, Grand Paris" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Curie - Section Medicale" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "Central European Cooperative Oncology Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "GFPC" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Institut Curie - Section Medicale" are "Lung Cancer" (4 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (4 trials), "Breast Cancer" (2 trials), "Leukemia" (2 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Institut Curie - Section Medicale" in a lesser frequency.

Most popular intervention types in "Institut Curie - Section Medicale" are "Drug" (21 trials), "Radiation" (11 trials), "Procedure" (6 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (8 trials), "cisplatin" (3 trials), "etoposide" (3 trials), "cytarabine" (2 trials) and "docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut Curie - Section Medicale" are 25 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Curie - Section Medicale". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Institut Curie - Section Medicale, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Curie - Section Medicale, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".